Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors from the central anxious process, conolidine modulates alternate molecular targets. A Science Improvements study found that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. https://alternative-natural-pain75062.aboutyoublog.com/47250526/the-basic-principles-of-alternative-natural-pain-relief-to-replace-traditional-painkillers